Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
US5250286A · kind A · utility
9Cited by
2References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 27, 1991 |
| Grant date | Oct 5, 1993 |
| Priority date | — |
| Expiry date | Nov 27, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/415
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of using an imidazoline compound, which is a vasodilator and an alpha-adrenergic blocking agent, for the treatment of symptoms of chronic obstructive pulmonary diseases (COPD), including cystic fibrosis, chronic bronchitis and emphysema, or COPD where it is associated with asthma, comprises administering the imidazoline to a patient by inhalation. Preferably, the imidazoline compound employed is tolazoline. The presentation of an imidazoline compound in a device for the administration of an aerosol is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.